author-photo

Jonathan Hersch

Memorial Sloan Kettering Cancer Center

5

Papers

8

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Systemic Chemotherapy for Metastatic Colitis-Associated Cancer has a Worse Outcome than for Sporadic Colorectal Cancer: a Matched Case Cohort Analysis

2020 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Outcomes for matched patients with metastatic colitis-associated cancers versus sporadic colorectal cancer receiving chemotherapy.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Balancing RAF, MEK, and EGFR Inhibitor Doses to Achieve Clinical Responses and Modulate Toxicity in BRAF V600E Colorectal Cancer

2018
Show All
- Source
- Cite
- Save
Citations (3)
A phase I expansion study of trifluridine and tipiracil (FTD/TPI) in combination with irinotecan (IRI) and bevacizumab (BEV) in patients with metastatic colorectal cancer (mCRC).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)